An immunological approach to chronic and recurrent sinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 15, Issue 1, 2007, Pages 10-17

  Wise, Marshall T ^a   Hagaman, David D ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Chronic rhinosinusitis; Chronic sinusitis; Immune deficiency

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DECONGESTIVE AGENT; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYMETAZOLINE; PHENYLEPHRINE; QUINOLONE; STEROID;

ALLERGIC RHINITIS; ANTIBODY RESPONSE; BRONCHOPULMONARY ASPERGILLOMA; CHRONIC HYPERPLASTIC EOSINOPHILIC SINUSITIS; CHRONIC RHINOSINUSITIS; CHRONIC SINUSITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG SENSITIVITY; DRUG SENSITIZATION; ENDOSCOPY; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; LOW DRUG DOSE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RHINOSINUSITIS; SARCOIDOSIS; SINUSITIS; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME;

CHRONIC DISEASE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULINS, INTRAVENOUS; RECURRENCE; SINUSITIS;

EID: 33846063824     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328011bcbf     Document Type: Review

References (79)

1. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999; 103:408-414.
2. Benninger MS, Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: Summary of the Agency for Healthcare Policy and Research evidence-based report. Otolaryngol Head Neck Surg 2000; 122:1-7.
3. National Center for Health Statistics. National Ambulatory Medical Care Survey, 1990-1995; Series 13 [CD-ROM]. Hyattsville, MD: National Center for Health Statistics.
4. Lau J, Zucker D, Engels EA, et al. Agency for Healthcare Policy and Research. Diagnosis and treatment of acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) 1999; 9:1-5.
5. Gwaltney JM. Acute community acquired sinusitis. Clin Infect Dis 1996; 23:1209-1223.
6. Jackson LL, Kountakis SE. Classification and management of rhinosinusitis and its complications. Otolaryngol Clin North Am 2005; 38:1143-1153. This article provides a definition of chronic rhinosinusitis.
7. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992; 102:1-18.
8. Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108:151-157.
9. Hamilos D. Chronic sinusitis. J Allergy Clin Immunol 2000; 106:213-227.
10. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head and Neck Surg 2003; 129:S1-S32.
11. Nagi MM, Desrosiers MY. Algorithms for management of chronic rhinosinusitis. Otolaryngol Clin North Am 2005; 38:1137-1141.
12. Bahattacharyya N, Kepnes LJ. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1999; 125:1117-1120.
13. Fairbanks DN. Inflammatory diseases of the sinuses: bacteriology and antibiotics. Otolaryngol Clin North Am 1993; 26:549-559.
14. Brook I. The role of bacteria in chronic rhinosinusitis. Otolaryngol Clin North Am 2005; 38:1171-1192.
15. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998; 316:13-20.
16. Biel MA, Brown CA, Levinson RM, et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998; 107 (11 Pt 1):942-945.
17. Spector SL, Bernstein L. Practice parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998; 102:S107-S144.
18. Walker C, Williams H, Phelan J. Allergic rhinitis history as a predictor of other future disqualifying otorhinolaryngological defects. Aviat Space Environ Med 1998; 69:952-956.
19. Lane AP, Pine HS, Pillsbury HC. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg 2001; 124:9-15.
20. Krouse J. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg 2000; 123:389-391.
21. Ramadan HH, Fornelli R, Ortiz AO, et al. Correlation of allergy and severity of sinus disease. Am J Rhinol 1999; 13:345-347.
22. Baroody FM, Suh SH, Naclerio RM. Total IgE serum levels correlate with sinus mucosal thickness on CT. J Allergy Clin Immunol 1997; 100:563-568.
23. Braun JJ, Alabert JP, Michel FB, et al. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy (Denmark) 1997; 52:650-655.
24. Nishioka GJ, Cook PR, Davis WE, et al. Immunotherapy in patients undergoing functional endoscopic sinus surgery. Otolaryngol Head Neck Surg 1994; 110:406-412.
25. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494-508.
26. Chalton R, Mackay I, Wilson R, Cole P. Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. Br Med J (Clin Res Ed) 1985; 291:788.
27. Keith P, Nieminen J, Hollingworth K, et al. Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000; 30:1460-1468.
28. Damm M, Jungehulsing M, Eckel HE, et al. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 1999; 120:517-523.
29. Kleinjan A, Holm AF, Dijkstra MD, et al. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA-expressing cells before and during a single nasal allergen provocation. Clin Exp Allergy 2000; 30:1476-1485.
30. Di Lorenzo G, Gervasi F, Drago A, et al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin Exp Allergy 1999; 29:1367-1377.
31. Chee L, Graham SM, Carothers DG, et al. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope 2001; 111:233-235.
32. Polmar SH. The role of immunologist in sinus disease. J Allergy Clin Immunol 1982; 90:511-515.
33. Wheeler JG, Steiner D. Evaluation of humoral responsiveness in children. Pediatr Infect Dis J 1992; 11:304-310.
34. Huston DPO, Kavanaugh AF, Rohane PW, Huston MM. Immunoglobulin deficiency syndromes and therapy. J Allergy Clin Immunol 1991; 87:1-17.
35. International Union of Immunological Societies. Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin Exp Immunol 1999; 118(Suppl 1):1-28.
36. Conley ME, Nortarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol 1999; 93:190-197.
37. Butler WT, Rossen RD. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest 1973; 52:2629-2640.
38. Bonilla F, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94:S1-S63. This article provides a definition for selective IgA deficiency as well as other disorders of primary immunodeficiency.
39. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120:225-231.
40. Gustafson R, Gardulf A, Granert C, et al. New strategy for prophylactic therapy to patients with 'selective' IgA deficiency. Lancet 1997; 350:865.
41. Beard LJ, Ferrante A. IgG4 deficiency in IgA deficient patients. Pediatr Infect Dis J 1989; 8:705-709.
42. Sethi DS, Fleopold DA. Diagnosis and management of chronic recurrent sinusitis and immunoglobulin deficiency. Curr Opin Otolaryngol Head Neck Surg 1995; 3:21-25.
43. Soderstrom T, Soderstrom R, Avanzini A, et al. Immunoglobulin G subclass deficiency. Int Arch Allergy Appl Immunol 1987; 82:476-480.
44. Shackelford PG, Polmar SH, Mayus JL, et al. Spectrum of IgG2 subclass deficiency in children with recurrent infections: prospective study. J Pediatr 1987; 108:647-653.
45. Berger M. Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J Pediatr 1987; 110:325-328.
46. Stanley PJ, Corbo G, Cole PJ. Serum IgG subclasses in chronic and recurrent respiratory infections. Clin Exp Immunol 1984; 58:703-708.
47. Umetsu DT, Ambrosino DM, Quinti I, et al. Recurrent sinopulmonary infections and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG subclass deficiency. N Engl J Med 1985; 313:1247-1251.
48. Shapiro GG, Virant FS, Furukawa CT, et al. Immunologic defects in patients with refractory sinusitis. Pediatrics 1991; 87:311-316.
49. Armenaka M, Grizzanti J, Rosenstreich DL. Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Ann Allergy 1994; 72:507-514.
50. Slavin RG, Spector SL, Bernstein IL, et al. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116:S13-S48.
51. Bjorkander J, Bake B, Oxelius VA, et al. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IbG3. N Engl J Med 1985; 313:720-724.
52. Oxelius VA. Chronic infections in a family with hereditary deficiency in IgG2 and IgG4. Clin Exp Immunol 1974; 17:9-17.
53. Gigliotti F, Herrod HG, Kalwinsky DK, et al. Immunodeficiency associated with recurrent infection and an isolated in vivo inability to respond to bacterial polysaccharides. Pediatr Infect Dis J 1988; 7:417-420.
54. Grubb R, Hallberg T, Hammarstrom L, et al. Correlation between deficiency of immunoglobulin subclass G3 and Gm allotype. Acta Pathol Microbiol Immunol Scand 1986; 94:187-191.
55. Shelley CS, Remold OE, Davis AE, et al. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA 1989; 86:2819-2823.
56. Rosen FS, Cooper M, Wedgwood R. The primary immunodeficiencies, part 2. N Engl J Med 1984; 311:300-310.
57. Sprecht TJ, Rahm SJ, Longworth DI, Keys TF. Frequency of sinusitis in AIDS patients. In: Proceedings of the IV International AIDS conference; 12-16 June 1988; Stockholm; p. 399.
58. Lamprecht J, Wiedbrauck C. Sinusitis and other typical ENT diseases within the scope of acquired immunologic deficiency syndrome (AIDS) [in German]. HNO 1988; 36:489-492.
59. Godofsky EW, Zinreich J, Armstrong M, et al. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med 1992; 93:163-170.
60. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-458.
61. Spector SL, Bernstein IL. Practice parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998; 102:S107-S144.
62. DeShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96:24-35.
63. Cody DT II, Neel HB III, Ferreiro JA, Roberts GD. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope 1994; 104:1074-1079.
64. Kuhn FA, Javer AR. Allergic fungal rhinosinusitis: our experience. Arch Otolaryngol Head Neck Surg 1998; 124:1179-1180.
65. Manning SC, Mabry RL, Schaefer SD, Close LG. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope 1993; 103:717-721.
66. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 1998; 108:1485-1496.
67. Study PR. Sarcoidosis. In: Brewis RAL, Gibson GJ, Geddes DM, editors. Respiratory medicine. London: Bailliere Tindall; 1990. pp. 1133-1139.
68. DeShazo RD, O'Brien MM, Justice WK, et al. Diagnostic criteria for sarcoidosis of the sinuses. J Allergy Clin Immunol 1999; 103 (5 Pt 1): 789-795.
69. Samter MF, Beers RF Jr. Concerning the nature of intolerance to aspirin. J Allergy 1967; 40:281-293.
70. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104:5-13.
71. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 1996; 26:807-814.
72. Hamilos DL, Leung DY, Wood R, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocytemacrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993; 92:39-48.
73. Amrol D, Murray JJ. Alternative medical treatment strategies of chronic hyperplastic eosinophilic sinusitis. Curr Opin Otolaryngol Head Neck Surg 2005; 13:55-59. This article examines the medical management of CHES.
74. Gotfried M. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125:52S-61S.
75. Hashiba M, Baba S. Efficacy of long term administration of clarithromycin in the treatment of intractable sinusitis. Acta Otolaryngol 1996; 525(suppl):73-78.
76. Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116:189-193. This article discusses the risks and benefits of long-term macrolide treatment of CRS.
77. Sheldon L, Spector MD, Leonard I, Bernstein MD. Practice parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998; 102:S107-S144.
78. King VV. Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy 1991; 9:143-157.
79. Moss RB, King VV. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Pediatr Pulmonol 1995; 21:566-572.